This December, the Foreign Corrupt Practices Act ‘‘celebrates’’ its 30th anniversary. Enacted in 1977 in response to widespread post-Watergate allegations that U.S. companies were securing foreign government contracts by making improper payments to foreign government officials, the FCPA generally prohibits U.S. companies and their personnel from paying or offering anything of value to foreign officials in order to obtain or retain business.
Click the link below to read the full article.
Reproduced with permission from White Collar Crime Report, Vol. 02, No. 09 (May 25, 2007), p. 286. Copyright 2007 by The Bureau of National Affairs, Inc. (800-372-1033) <http://www.bna.com>
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.